Q1: 2026-05-12 Earnings Summary EPS of -$0.43 beats by $0.14  |  Revenue of $7.48M (529.67% Y/Y) beats by $295.62K Nyxoah SA ( NYXH ) Bank of America Global Healthcare Conference 2026 May 13, 2026 8:15 PM EDT Company Participants Olivier Taelman - CEO & Executive Director Presentation Unknown Analyst I'm on the medtech team here at Bank of America. Really happy to introduce our next presenter, Nyxoah. We have CEO, Olivier Taelman, to present. Olivier Taelman CEO & Executive Director Good afternoon, everyone. First of all, thank you, and thank you, Bank of America, for having us and to be able to explain a little bit and talk a little bit more about the Nyxoah story. When we talk about Nyxoah, we are talking about obstructive sleep apnea and the treatment of obstructive sleep apnea by offering a neuromodulation solution. Before I dig in a little bit further into our technology, I would like to talk a little bit more about the market space.…